The objective of this study was to "critically assess the evidence presented in randomized controlled trials (RCTs) about the effectiveness of acupuncture on fatigue in cancer patients". In April 2024 ...
Patients receiving the tafasitamab combination achieved a median PFS of 22.4 months, compared with 13.9 months for patients receiving placebo with lenalidomide and rituximab. This represents a 57% ...
Ribupatide (KAI-9531) aims to address critical need for greater weight loss, especially for people living with a BMI of 35 kg/m2 or greater - ...
FDA authorizes compassionate use of urcosimod for neuropathic corneal pain, a condition that causes severe pain and ...
Janus kinase (JAK) inhibitors, including baricitinib, block cytokine signaling and are effective disease-modifying treatments for several autoimmune diseases. Whether baricitinib preserves β-cell ...
How can we tell if a depression treatment works beyond placebo? A new real-world method measuring placebo shows that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results